Table 2 Table 2 [Version edited from original; see note below Table.]
 List of populations used in this study. Population codes are given, as well as sample size, number of U6 haplotypes detected, percentage of U6 in the sample, and the relative frequency (%) of the three U6 sub-groups.
Group
 Population
 Name
 sample
 HapU6
 U6(%)
 U6a(%)
 U6b(%)
 U6c(%)
 References
(See Original Article)
EAST (E)









Arab Bedouin
 ABD
 29
 1
 2 (7)
 -
 2 (100)
 -
 22

 Egyptians
 EGY
 67
 1
 1 (1)
 1 (100)
 -
 -
 46

 Ethiopian
 ETI
 74
 3
 3 (4)
 3 (100)
 -
 -
 14

 Iraqi
 IRQ
 116
 1
 1 (1)
 1 (100)
 -
 -
 47

 Ashkenazic Jew
 JAS
 78
 2
 3 (4)
 3 (100)
 -
 -
 14

 Bukharan Jew
 JBU
 33
 1
 1 (3)
 1 (100)
 -
 -
 14

 Ethiopian Jew
 JET
 48
 1
 1 (2)
 1 (100)
 -
 -
 14

 Kikuyu
 KIK
 24
 1
 2 (8)
 2 (100)
 -
 -
 48

 Palestinian
 PAL
 109
 1
 1 (1)
 1 (100)
 -
 -
 47

 Syrians
 SYR
 69
 2
 3 (4)
 3 (100)
 -
 -
 47
      Total E

647
 9
 18 (3)
 16 (89)
 2 (11)
 -
WEST (W)








           Europe









Med. Center
 MdC
 302
 1
 1 (0)
 -
 1 (100)
 -
 47

 Sicilian
 SIC
 106
 1
 1 (1)
 1 (100)
 -
 -
 13
           Iberian Peninsula (IP)

Andalusian
 AND
 397
 7
 10 (3)
 8 (80)
 2 (20)
 -
 9, 11, a

 Cat and Arag�n
 CAR
 118
 2
 2 (2)
 1 (50)
 1 (50)
 -
 49

 Castilla
 CAV
 38
 1
 1 (3)
 1 (100)
 -
 -
 11

 Le�n
 LEO
 61
 1
 1 (2)
 1 (100)
 -
 -
 11

 Galician
 GAL
 135
 3
 3 (2)
 1 (33)
 2 (67)
 -
 12, 50

 Maragatos
 MRG
 49
 2
 4 (8)
 1 (25)
 3 (75)
 -
 11

 Portugal Center
 PC
 162
 2
 3 (2)
 3 (100)
 -
 -
 10, 12

 Portuguese
 PCR
 54
 2
 3 (6)
 2 (67)
 1 (33)
 -
 a

 North Portugal
 PN
 184
 6
 8 (4)
 5 (63)
 3 (38)
 -
 10, 12

 Santander
 SAN
 88
 1
 1 (1)
 1 (100)
 -
 -
 38
      Total IP

1286
 18
 36 (3)
 24 (67)
 12 (33)
 -
           Islands









Canarian
 CAN
 300
 11
 53(18)
 4 (8)
 39 (74)
 10 (19)
 19

 Cabo Verde
 CV
 315
 5
 6 (2)
 6 (100)
 -
 -
 51, a

 Madeira
 MAD
 96
 1
 1 (1)
 1 (100)
 -
 -
 a

 Sao Tom�
 SAT
 50
 1
 1 (2)
 1 (100)
 -
 -
 52
      Total Islands

761
 15
 61 (8)
 12 (20)
 39 (64)
 10 (16)
           West Africa (WA)

Algerian Berbers
 BAL
 86
 5
 25 (29)
 24 (96)
 1 (4)
 -
 9, a

 Ifrane Berbers
 BIF
 46
 7
 9 (20)
 8 (89)
 1 (11)
 -
 14

 Moroccan Ber.
 BMO
 213
 11
 15 (7)
 11 (73)
 1 (7)
 3 (20)
 4, 14, 53, a

 Fulbe
 FUL
 60
 2
 2 (3)
 1 (50)
 1 (50)
 -
 48

 Mauritanian
 MAU
 64
 4
 11 (17)
 11 (100)
 -
 -
 4, a

 Moroccan
 MOR
 56
 6
 11 (20)
 8 (73)
 -
 3 (27)
 4, a

 Saharan
 SAH
 37
 2
 3 (8)
 3 (100)
 -
 -
 4, a

 Mandenka
 SEM
 119
 1
 1 (1)
 1 (100)
 -
 -
 54

 Wolof
 SEW
 48
 2
 2 (4)
 1 (50)
 1 (50)
 -
 4

 Songhai
 SON
 10
 1
 2 (20)
 2 (100)
 -
 -
 48

 Tuareg
 TUA
 23
 1
 1 (4)
 1 (100)
 -
 -
 48
      Total WA

762
 27
 82 (11)
 71 (87)
 5 (6)
 6 (7)
          
AMERICA









Brazilian
 BRA
 247
 2
 4 (2)
 4 (100)
 -
 -
 16

 Cuban patients
 CUB
 4
 1
 3 (75)
 -
 3 (100)
 -
 15

 TOTAL
 56
 206
 128(62)
 62 (30)
 16 (8)



[Note, emphasis and/or editorial discussion has been added in places through the use of bolding, italics, [], and/or colored highlighting or text, together with links to commentary found in the article "The Phoenician Hypothesis: An mtDNA Note re the phylogeographic occurances of mtDNA Haplotype U6b as related to the Results found in testing of FTDNA Kits #6582 and #24245" at: http://freepages.genealogy.rootsweb.com/~donegalstrongs/u6b.htm ]
The above Table is an edited reproduction of Table 2 as found in the original study:
"Mitochondrial DNA transit between West Asia and North Africa inferred from U6 phylogeography", by Nicole Maca-Meyer1 , Ana M Gonz�lez1 , Jos� Pestano2 , Carlos Flores1 , Jos� M Larruga1 and Vicente M Cabrera1; of the
1Departamento de Gen�tica, Facultad de Biolog�a, Universidad de La Laguna, Tenerife, SPAIN
2Laboratorio de Gen�tica, Facultad de Medicina, Universidad de Las Palmas de Gran Canaria, Gran Canaria, SPAIN
Published in BMC Genetics 2003, 4:15
doi:10.1186/1471-2156-4-15
The complete electronic version of this article can be found online at:
http://www.biomedcentral.com/1471-2156/4/15
Received 8 July 2003
Accepted 16 October 2003
Published 16 October 2003

[� 2003 Maca-Meyer et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL. ]